148 related articles for article (PubMed ID: 1721470)
1. Sporadic loss of leucocyte-function-associated antigen-3 (LFA-3) in colorectal carcinomas.
Koretz K; Schlag P; Möller P
Virchows Arch A Pathol Anat Histopathol; 1991; 419(5):389-94. PubMed ID: 1721470
[TBL] [Abstract][Full Text] [Related]
2. Frequency of abnormal expression of HLA-A,B,C and HLA-DR molecules, invariant chain, and LFA-3 (CD58) in colorectal carcinoma and its impact on tumor recurrence.
Möller P; Koretz K; Schlag P; Momburg F
Int J Cancer Suppl; 1991; 6():155-62. PubMed ID: 1712347
[TBL] [Abstract][Full Text] [Related]
3. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma.
Möller P; Momburg F; Koretz K; Moldenhauer G; Herfarth C; Otto HF; Hämmerling GJ; Schlag P
Cancer Res; 1991 Jan; 51(2):729-36. PubMed ID: 1985791
[TBL] [Abstract][Full Text] [Related]
4. Expression of epithelial antigens EPM-1 and EXO-1 in normal, transitional, inflammatory and neoplastic colorectal mucosa.
Klingel R; Real FX; Meyer zum Büschenfelde KH; Dippold WG
Eur J Cancer; 1993; 29A(12):1723-8. PubMed ID: 8398302
[TBL] [Abstract][Full Text] [Related]
5. Expression of HLA class I antigens in sporadic adenomas and histologically normal mucosa of the colon.
Tsioulias GJ; Triadafilopoulos G; Goldin E; Papavassiliou ED; Rizos S; Bassioukas P; Rigas B
Cancer Res; 1993 May; 53(10 Suppl):2374-8. PubMed ID: 8485724
[TBL] [Abstract][Full Text] [Related]
6. Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas.
Koretz K; Brüderlein S; Henne C; Möller P
Br J Cancer; 1992 Nov; 66(5):810-4. PubMed ID: 1384641
[TBL] [Abstract][Full Text] [Related]
7. Selective and non-selective loss of immunoregulatory molecules (HLA-A,B,C antigens and LFA-3) in transitional cell carcinoma.
Nouri AM; Smith ME; Crosby D; Oliver RT
Br J Cancer; 1990 Oct; 62(4):603-6. PubMed ID: 1699592
[TBL] [Abstract][Full Text] [Related]
8. Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients.
Mulder WM; Stern PL; Stukart MJ; de Windt E; Butzelaar RM; Meijer S; Adér HJ; Claessen AM; Vermorken JB; Meijer CJ; Wagstaff J; Scheper RJ; Bloemena E
Clin Cancer Res; 1997 Nov; 3(11):1923-30. PubMed ID: 9815581
[TBL] [Abstract][Full Text] [Related]
9. Expression of HLA-DR antigen and characterization of the lymphocytic infiltrate in normal mucosa, tubulo-villous adenoma and invasive carcinoma of the colon.
Tamiolakis D; Venizelos J; Papadopoulos N; Lambropoulou M; Papadopoulos E; Simopoulos C
Chirurgia (Bucur); 2005; 100(5):451-6. PubMed ID: 16372671
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD59, a complement regulator protein and a second ligand of the CD2 molecule, and CD46 in normal and neoplastic colorectal epithelium.
Koretz K; Brüderlein S; Henne C; Möller P
Br J Cancer; 1993 Nov; 68(5):926-31. PubMed ID: 7692919
[TBL] [Abstract][Full Text] [Related]
11. Expression of leucocyte adhesion molecules on 66 clinical neuroblastoma specimens.
Favrot MC; Combaret V; Goillot E; Tabone E; Bouffet E; Dolbeau D; Bouvier R; Coze C; Michon J; Philip T
Int J Cancer; 1991 Jun; 48(4):502-10. PubMed ID: 1710608
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric investigation of immune-response-related surface molecules on human colorectal cancers.
Diederichsen AC; Stenholm AC; Kronborg O; Fenger C; Jensenius JC; Zeuthen J; Christensen PB; Kristensen T
Int J Cancer; 1998 Jun; 79(3):283-7. PubMed ID: 9645352
[TBL] [Abstract][Full Text] [Related]
13. Inverse correlation between HLA-DR antigen expression and CD4 positive lymphocytic populations in normal mucosa, tubulovillous adenoma, and invasive carcinoma of the colon.
Tamiolakis D; Venizelos I
Cesk Patol; 2006 Apr; 42(2):52-8. PubMed ID: 16715627
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of carcinoembryonic antigen and epithelial membrane antigen expression in normal colon, adenomas and adenocarcinomas of the colon and rectum.
Davidson BR; Sams VR; Styles J; Dean C; Boulos PB
Gut; 1989 Sep; 30(9):1260-5. PubMed ID: 2806995
[TBL] [Abstract][Full Text] [Related]
15. HLA antigens on colorectal adenoma and cancer cells.
Horie Y; Chiba M; Iizuka M; Igarashi K; Masamune O
Tohoku J Exp Med; 1990 Apr; 160(4):311-22. PubMed ID: 2382260
[TBL] [Abstract][Full Text] [Related]
16. Constitutive absence and interferon-gamma-induced expression of adhesion molecules in basal cell carcinoma.
Taylor RS; Griffiths CE; Brown MD; Swanson NA; Nickoloff BJ
J Am Acad Dermatol; 1990 May; 22(5 Pt 1):721-6. PubMed ID: 1693385
[TBL] [Abstract][Full Text] [Related]
17. Role of APAF-1, E-cadherin and peritumoral lymphocytic infiltration in tumour budding in colorectal cancer.
Zlobec I; Lugli A; Baker K; Roth S; Minoo P; Hayashi S; Terracciano L; Jass JR
J Pathol; 2007 Jul; 212(3):260-8. PubMed ID: 17516584
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation.
Chaux P; Moutet M; Faivre J; Martin F; Martin M
Lab Invest; 1996 May; 74(5):975-83. PubMed ID: 8642792
[TBL] [Abstract][Full Text] [Related]
19. Disease-free survival of colorectal cancer patients in relation to CDw75 antigen expression.
Villar-Portela S; Muinelo-Romay L; Cuevas E; Gil-Martín E; Fernández-Briera A
Pathobiology; 2011; 78(4):201-9. PubMed ID: 21778787
[TBL] [Abstract][Full Text] [Related]
20. Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition.
Griffin H; Rowe M; Murray R; Brooks J; Rickinson A
Eur J Immunol; 1992 Jul; 22(7):1741-8. PubMed ID: 1378014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
